[amazon_link asins=’0702253480,B06XPD68VT,B00Q0MNE7S,B01C7ZE272,B06XBJ2ZLT,B01MS6GD1H,B01N40XESK,0190497033,B06XRVWLWV’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’00689ec2-4df2-11e7-bd78-0d6b445b7550′]
Stents, used in angioplasty procedures, are thinner, coated with new drugs which were more effective in prevention of re-narrowing.
Stents also have biocompatible, biodegradable polymer which dissolves by itself after six months, thus reducing chances of clot formation, Dr Sunil Kapoor, Chief Cardiologist at Care Hospitals, who attended the conference, said here today.
He said that data presented in the USA showed new generation stents were significantly superior to the previously used standard, drug coated stents. Head-to-head comparison was done in the trials. The same stents have been made available in Hyderabad and used successfully, Dr Kapoor said.
“We have used the new technology-Stents and find them to be very good and data shows that re-narrowing and second heart attack can be prevented 98%. These stents have lesser chance of re-narrowing (only 1.5%) and clot formation in the stents was found to be zero per cent upto two years of follow up. This is likely to make Stents equal to bypass surgery. If not superior, but without the complications of surgery,” he said.
“This is a very significant development for treatment of heart patients and makes angioplasty and Stent procedures easier, safer and with better long lasting effect,” Dr Kapoor added.
Sources: The Times Of India